Trial Profile
A clinical trial for NSI-566 in chronic stroke in China
Status:
Planning
Phase of Trial:
Phase I
Latest Information Update: 28 Feb 2022
Price :
$35
*
At a glance
- Drugs NSI 566 (Primary)
- Indications Stroke
- Focus Adverse reactions
- 22 May 2018 New trial record
- 15 May 2018 According to a Neuralstem media release, this study may expected to start in mid-2018